Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMHM8ZK)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Propoxycaine hydrochloride; Ravocaine hydrochloride; 550-83-4; Propoxycaine HCl; Propoxycaine (hydrochloride); Pravocaine hydrochloride; UNII-K490D39G46; WIN 3459; EINECS 208-988-7; Propoxycaine hydrochloride [USP]; K490D39G46; 2-(Diethylamino)ethyl 4-amino-2-propoxybenzoate monohydrochloride; 4-Amino-2-propoxybenzoic acid 2-(diethylamino)ethyl ester hydrochloride; Propoxycaine hydrochloride (USP); BENZOIC ACID, 4-AMINO-2-PROPOXY-, 2-(DIETHYLAMINO)ETHYL ESTER, MONOHYDROCHLORIDE; C16H26N2O3; NCGC00016505-01; CAS-550-83-4
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||
|
||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Colon
Colorectal adenocarcinoma
Hematopoietic system
Normal
Kidney
Normal (Immortalized)
Liver
Hepatoblastoma
Lung
Lung adenocarcinoma
Non-small cell lung carcinoma
Prostate
Prostate carcinoma
Skin
Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
